Novo Nordisk A/S Class B (NOVCb)

99.00
+0.40(+0.41%)
  • Volume:
    20
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    99.00 - 99.00
  • Type:Equity
  • Market:Germany
  • ISIN:DK0060534915
  • WKN:A1XA8R

NOVCb Comments

What is your sentiment on Novo Nordisk B?
or
Vote to see community's results!

All Comments

(14)
  • Does anyone no of a particular reason that NOVO B is going so far down today? Is it profit taking before Q1 2022 results?
    0
    • New Target 825 by EOM
      0
      • New Target 825
        0
        • Consolidating nicely for leg up to 850!🌟
          0
          • Results from clinical study just published in New England Journal of Medicine: Impressive new weight loss results for Semaglutide at only 2.4 mg once a week. Drug mimics the gut hormone glucagon-like peptide-1 (GLP-1) that is secreted by your gut after eating.
            1
            • Now is the time to buy - novo is very seasonal stock goes up the most in jan/feb.
              0
              • bullish??
                0
                • No. Funds are selling. Time to wait to go long...
                  0
              • Perfect opportunity to make short,,
                1
                • can you explain why please?
                  0
                • No explaning? 🤷
                  0
                • because he has no explanation. Novo nordisk is a soli long-term stock. I know a lot about opioid treatments, and methadon is changing to lipo-methadon, wich has really only one competitor on the global field. That competitor is Camurus AB with their product buvidol. I tecommend to all investors to buy and HOLD for these two companies, because there is no other options for a opioid-replacement-care, except Suboxone, and that is going to be replaced Lipo-methadon or Buvidol, at least here in Finland. Suboxone is manufactured for Indivor Inc, by Aquestive Therapeutics, if someone wants to do a little research.
                  0
              • Bullish sentiment.
                0
                • Why is going so low???
                  0
                  • Anyone got a view on how much the Trump/US plans to reduce medical prices will affect the share price?
                    0
                    • Extremely bullish double bottom pattern and fibbonacci retracement with convergence of relative strenght index upwards
                      0
                      • Comenté hace unos meses que es un valor muy sólido, que lo veríamos pronto en 200 $ (que con el split son 40 $), pues bien, ha superado mis expectativas y está en 45 $.... me aventuro a pronosticar que cerrará el año en torno a los 50 $. Saludos
                        0
                        • Comenté hace unos meses que es un valor muy sólido, que lo veríamos pronto en 200 $ (que con el split son 40 $), pues bien, ha superado mis expectativas y está en 45 $.... me aventuro a pronosticar que cerrará el año en torno a los 50 $. Saludos
                          0